(919) 224-8800 Contact Our Team

Learn how sponsors and CROs are tackling the challenge of developing a comprehensive drug development strategy.  We'll also discuss how issues such as slow study enrollment, trial designs that do not meet regulatory expectations, or prohibitively expensive raw materials can be more easily managed or avoided altogether.

Who Should Listen:  Trial sponsors, clinicians, regulatory experts, and site personnel wanting to learn more about considerations for developing a comprehensive drug development strategy.

What You'll Learn:  

  • Three foundational questions to consider that form a base for building specific sections of your comprehensive drug development strategy
  • Best practices for strategic planning in five key areas:
    • Regulatory
    • Manufacturing/quality
    • Preclinical/nonclinical development
    • Clinical development


  • Brenda Fielding, Executive Vice President, Regulatory Affairs
  • Monika Frey, Vice President, Global Clinical Operations
  • Nik Burlew, Vice President, Quality Systems

Free Webcast:

Mapping a Path to Market: Creating a Comprehensive Drug Development Strategy

Download the webcast now!